2Strangfeld A,Eveslage M,Schneider M,et al.Treatment benefit or survival of the fittest:what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient[J] ?Ann Rheum Dis,2011,70(11):1914-1920.
3Kowalczyk W,Rybicki Z,Tomaszewski D,et al.The comparison of different bronchial aspirate culturing methods in patients with ventilator-associated pneumonia[J].Anestezjol Intens Ter,2011,43(2):74-79.
4Manali E,Papadopoulos A,Tsiodras S,et al.The impact on community acquired pneumonia empirical therapy of diagnostic bronchoscopic techniques[J].Scand J Infect Dis,2008,40(4):286-292.
5Cosgrove SE,Ristaino P,Caston-Gaa A,et al.Caveat emptor:the role of suboptimal bronchoscope repair practices by a third-party vendor in a pseudo-outbreak of pseudomonas in bronchoalveolar lavage specimens[J].Infect Control Hosp Epidemiol,2012,33(3):224-229.
6Veres J,Slavei K,Errhalt P,et al.The Veres adapter:clinical experience with a new device for jet ventilation via a laryngeal mask airway during flexible bronchoscopy[J].Anesth Analg,2011,112(3):597-600.
